abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - agentes antineoplásicos - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
xtandi
astellas pharma europe b.v. - enzalutamida - neoplasmas prostáticos - terapia endocrina - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
zinforo
pfizer ireland pharmaceuticals - ceftaroline fosamil - community-acquired infections; skin diseases, infectious; pneumonia - antibacterianos para uso sistémico, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.
secnidazol 500 mg tabletas recubiertas
laboratorios valmor, c.a. - secnidazol - tableta recubierta - 500 mg(a4)
blenrep
glaxosmithkline (ireland) limited - belantamab mafodotin - mieloma múltiple - agentes antineoplásicos - blenrep is indicated as monotherapy for the treatment of multiple myeloma in adult patients, who have received at least four prior therapies and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
apelka 5 mg/ml solucion oral para gatos
norbrook laboratories (ireland) limited - tiamazol - soluciÓn oral - tiamazol 5 - tiamazol - gatos
amoxipol 100 mg/g # amoxipol premezcla medicamentosa
andres pintaluba s.a. - amoxicilina trihidrato - premezcla medicamentosa - amoxicilina trihidrato 100 - amoxicilina - lechones destetados; lechones lactantes
amoxipol 200 mg/g premezcla medicamentosa
andres pintaluba s.a. - amoxicilina trihidrato - premezcla medicamentosa - amoxicilina trihidrato 200 - amoxicilina - lechones destetados; lechones lactantes
alizin 30 mg/ml solucion inyectable para perros # alizin 30 mg/ml solucion inyectable
virbac - aglepristona - soluciÓn inyectable - aglepristona 30 - aglepristona - perras gestantes
epirepress 100 mg comprimidos para perros
desitin arzneimittel gmbh - fenobarbital - comprimido - fenobarbital 100 - fenobarbital - perros